Business Context and Reporting Period
This Form 8-K is a current report filed by LabStyle Innovations Corp. (not Dariohealth Corp.) on November 14, 2013, regarding events occurring on November 12, 2013. The registrant is a Delaware corporation headquartered in Ramat Gan, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
The primary material change reported is the appointment of Dennis M. McGrath to the Board of Directors and the Audit Committee on November 12, 2013. Mr. McGrath brings significant experience as the President and Chief Financial Officer of PhotoMedex, Inc., and has previously served as CEO and CFO of public companies in the medical device and technology sectors.
Guidance, Outlook, and Risks
The filing includes a standard cautionary note regarding forward-looking statements. It warns that actual results may differ materially from expectations due to factors including negotiations with executives and consultants, as well as risks discussed in other SEC filings. The company undertakes no obligation to update these statements.
Investor Verification Checklist
- Verify the registrant name is LabStyle Innovations Corp., not Dariohealth Corp.
- Confirm the appointment of Dennis M. McGrath to the Board and Audit Committee.
- Review Mr. McGrath's background in the medical device industry and public company finance.
- Note that no financial performance data is included in this specific filing.